secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lucid Diagnostics Inc. (LUCD)
CIK:        0001799011
Form:       8-K
Filed at:   2023-02-17T23:59:59+00:00
Accession:  0001493152-23-005454
Event type: other_material
Sentiment:  positive
Materiality: 0.55
Item codes: 1.02, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lucid Diagnostics terminates MSA with ResearchDx, saves ~$2.7M
--------------------------------------------------------------

- Mutual termination of Management Services Agreement with ResearchDx effective Feb 10, 2023.
- Earnout and management fees reduced to $725,000 from ~$3,450,000, saving ~$2,725,000.
- Payment satisfied via 553,436 shares of common stock; no cash required.
- Termination enables full internal operation of LucidDx Labs' EsoGuard assay.
- Includes mutual release and customary covenants.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1799011/000149315223005454/0001493152-23-005454-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1799011/000149315223005454/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-005454

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer